← Back to Search

Protein Supplementation for Breast Cancer (NeoChemoPRT Trial)

Pittsburgh, PA
N/A
Recruiting
Led By Colin Champ, MD
Research Sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women with a biopsy proven diagnosis of invasive carcinoma of the breast
Women must undergo neoadjuvant chemotherapy for breast cancer treatment prior to surgery
Must not have
Males
Inability to get up and down off the ground or squat body weight
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at program completion (at 24 weeks)
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to see if giving cancer patients a high dose of protein after workouts and a specific exercise plan can help improve their body composition and physical abilities."

See full description
Who is the study for?
This trial is for women aged 20-89 with invasive breast cancer who are undergoing neoadjuvant chemotherapy before surgery. Participants must be able to perform physical exercises, read and understand English, and consent for themselves. It excludes those with severe health conditions that prevent exercise, lactose intolerance, allergies to cow's milk or whey protein, as well as pregnant women and males.Check my eligibility
What is being tested?
The study tests if high-load resistance training combined with a high dose of post-workout whey protein (either 20 grams or 60 grams) can improve body composition and functional capacity in women receiving chemotherapy for breast cancer.See study design
What are the potential side effects?
Potential side effects may include digestive discomfort due to the whey protein intake, especially in individuals sensitive to dairy products. The resistance training could cause muscle soreness or injury if not performed correctly.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with invasive breast cancer.
 show original
Select...
I am a woman receiving chemotherapy before breast surgery.
 show original
Select...
I am between 20 and 89 years old.
 show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am male.
 show original
Select...
I cannot squat or get up from the ground by myself.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at program completion (at 24 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at program completion (at 24 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Changes in EuroQol-5 Dimensions (EQ-5D) at completion of chemotherapy assessment
Changes in Functional Mobility Score at baseline and at completion of chemotherapy
Changes in General Anxiety Disorder-7 (GAD7) anxiety score at completion of chemotherapy assessment
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: 60 grams of proteinExperimental Treatment1 Intervention
Participants will be randomized (like flipping a coin) to a post-workout protein consisting of 60 grams of whey protein. The protein will be 100% cold processed and micro-filtered, non-GMO grass-fed whey protein isolate, soy and gluten free, unflavored, and unsweetened. This will include Irish Dairy, which is whey protein isolate and soy lecithin, and Raw GrassFed Whey, which is whey protein concentrate. Participants will not know which amount of protein they receive.
Group II: 20 grams of proteinExperimental Treatment1 Intervention
Participants will be randomized (like flipping a coin) to a post-workout protein consisting of 20 grams of whey protein. The protein will be 100% cold processed and micro-filtered, non-GMO grass-fed whey protein isolate, soy and gluten free, unflavored, and unsweetened. This will include Irish Dairy, which is whey protein isolate and soy lecithin, and Raw GrassFed Whey, which is whey protein concentrate. Participants will not know which amount of protein they receive.

Find a Location

Closest Location:Allegheny General Hospital· Pittsburgh, PA· 974 miles

Who is running the clinical trial?

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Lead Sponsor
51 Previous Clinical Trials
12,982 Total Patients Enrolled
Colin Champ, MDPrincipal InvestigatorAHN Radiation Oncology
3 Previous Clinical Trials
102 Total Patients Enrolled
~20 spots leftby Dec 2025